메뉴 건너뛰기




Volumn 11, Issue 1, 2011, Pages 85-99

Mood stabilizers for patients with bipolar disorder: The state of the art

Author keywords

acute treatment; anticonvulsants; atypical antipsychotics; bipolar disorder; depression; lithium; maintenance treatment; mania; mood stabilizers

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ASENAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

EID: 78650405997     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.181     Document Type: Review
Times cited : (33)

References (161)
  • 1
    • 70350161415 scopus 로고    scopus 로고
    • The role of lithium in modulation of brain genes: Relevance for aetiology and treatment of bipolar disorder
    • Fatemi SH, Reutiman TJ, Folsom TD. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder. Biochem. Soc. Trans. 37(Pt 5), 1090-1095 (2009).
    • (2009) Biochem. Soc. Trans. , vol.37 , Issue.PART 5 , pp. 1090-1095
    • Fatemi, S.H.1    Reutiman, T.J.2    Folsom, T.D.3
  • 2
    • 4043169722 scopus 로고    scopus 로고
    • Bipolar disorder a seriously underestimated health burden
    • Angst J. Bipolar disorder a seriously underestimated health burden. Eur. Arch. Psychiatry Clin. Neurosci. 254, 59-60 (2004).
    • (2004) Eur. Arch. Psychiatry Clin. Neurosci. , vol.254 , pp. 59-60
    • Angst, J.1
  • 4
    • 77957957255 scopus 로고    scopus 로고
    • Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication
    • Angst J, Cui L, Swendsen J et al. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am. J. Psychiatry 167(10), 1194-1201 (2010).
    • (2010) Am. J. Psychiatry , vol.167 , Issue.10 , pp. 1194-1201
    • Angst, J.1    Cui, L.2    Swendsen, J.3
  • 5
    • 34548387113 scopus 로고    scopus 로고
    • Is bipolar disorder overdiagnosed among patients with substance abuse?
    • Stewart C, El-Mallakh RS. Is bipolar disorder overdiagnosed among patients with substance abuse? Bipolar Disord. 9(6), 646-648 (2007).
    • (2007) Bipolar Disord. , vol.9 , Issue.6 , pp. 646-648
    • Stewart, C.1    El-Mallakh, R.S.2
  • 7
    • 33748427055 scopus 로고    scopus 로고
    • Comorbidity and bipolar disorders
    • Kahn JP. Comorbidity and bipolar disorders. Encephale 32(Pt 2), S511-S514 (2006).
    • (2006) Encephale , vol.32 , Issue.PART 2
    • Kahn, J.P.1
  • 8
    • 78650395628 scopus 로고    scopus 로고
    • Patterns of Axis i comorbidity in relation to age in patients with bipolar disorder: A cross-sectional analysis
    • DOI:10.1016/j.jad.2010.10.008 Epub ahead of print
    • DellOsso B, Buoli M, Bortolussi S, Vecchi V, Camuri G, Altamura AC. Patterns of Axis I comorbidity in relation to age in patients with bipolar disorder: a cross-sectional analysis. J. Affect. Disord. DOI:10.1016/j.jad.2010. 10.008 (2010) (Epub ahead of print).
    • (2010) J. Affect. Disord.
    • Dellosso, B.1    Buoli, M.2    Bortolussi, S.3    Vecchi, V.4    Camuri, G.5    Altamura, A.C.6
  • 9
    • 34247536530 scopus 로고    scopus 로고
    • Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication
    • Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 64(5), 543-552 (2007).
    • (2007) Arch. Gen. Psychiatry , vol.64 , Issue.5 , pp. 543-552
    • Merikangas, K.R.1    Akiskal, H.S.2    Angst, J.3
  • 10
    • 75249093111 scopus 로고    scopus 로고
    • Suicide attempts in bipolar i and bipolar II disorder: A review and meta-analysis of the evidence
    • Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 12, 1-9 (2010).
    • (2010) Bipolar Disord. , vol.12 , pp. 1-9
    • Novick, D.M.1    Swartz, H.A.2    Frank, E.3
  • 11
    • 61649096163 scopus 로고    scopus 로고
    • A systematic review of the evidence of the burden of bipolar disorder in Europe
    • Fajutrao L, Locklear J, Priaulx J et al. A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin. Pract. Epidemiol. Ment. Health 5, 3 (2009).
    • (2009) Clin. Pract. Epidemiol. Ment. Health , vol.5 , pp. 3
    • Fajutrao, L.1    Locklear, J.2    Priaulx, J.3
  • 14
    • 0030010429 scopus 로고    scopus 로고
    • Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment
    • Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J. Clin Psychopharmacol. 16(2 Suppl. 1), S32-S47 (1996).
    • (1996) J. Clin Psychopharmacol. , vol.16 , Issue.2 SUPPL. 1
    • Sachs, G.S.1
  • 15
    • 1442289924 scopus 로고    scopus 로고
    • What is a mood stabilizer? An evidence-based response
    • Bauer MS, Mitchner L. What is a mood stabilizer? An evidence-based response. Am. J. Psychiatry 161(1), 3-18 (2004).
    • (2004) Am. J. Psychiatry , vol.161 , Issue.1 , pp. 3-18
    • Bauer, M.S.1    Mitchner, L.2
  • 17
    • 0036179509 scopus 로고    scopus 로고
    • Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature
    • Ketter TA, Calabrese JR. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J. Clin Psychiatry 63, 146-151 (2002).
    • (2002) J. Clin Psychiatry , vol.63 , pp. 146-151
    • Ketter, T.A.1    Calabrese, J.R.2
  • 18
    • 0038642170 scopus 로고    scopus 로고
    • Selecting effective long-term treatment for bipolar patients: Monotherapy and combinations
    • Grof P. Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J. Clin. Psychiatry 64(Suppl. 5), 53-61 (2003).
    • (2003) J. Clin. Psychiatry , vol.64 , Issue.SUPPL. 5 , pp. 53-61
    • Grof, P.1
  • 19
    • 0346025634 scopus 로고    scopus 로고
    • Mood-stabilizers: The archeology of the concept
    • Harris M, Chandran S, Chakraborty N et al. Mood-stabilizers: the archeology of the concept. Bipolar Disord. 5, 446-452 (2003).
    • (2003) Bipolar Disord. , vol.5 , pp. 446-452
    • Harris, M.1    Chandran, S.2    Chakraborty, N.3
  • 21
    • 65249143218 scopus 로고    scopus 로고
    • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009
    • Yatham LN, Kennedy SH, Schaffer A et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 11(3), 225-255 (2009).
    • (2009) Bipolar Disord. , vol.11 , Issue.3 , pp. 225-255
    • Yatham, L.N.1    Kennedy, S.H.2    Schaffer, A.3
  • 22
    • 16544379823 scopus 로고    scopus 로고
    • On behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders the World Federation of Societies of Biological Psychiatry (WFSBP). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment
    • Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ; on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders The World Federation of Societies of Biological Psychiatry (WFSBP). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J. Biol. Psychiatry 5, 120-135 (2004).
    • (2004) World J. Biol. Psychiatry , vol.5 , pp. 120-135
    • Grunze, H.1    Kasper, S.2    Goodwin, G.3    Bowden, C.4    Möller, H.J.5
  • 23
    • 67650134119 scopus 로고    scopus 로고
    • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania
    • Grunze H, Vieta E, Goodwin G et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the treatment of acute mania. World J. Biol. Psychiatry 10, 85-116 (2009).
    • (2009) World J. Biol. Psychiatry , vol.10 , pp. 85-116
    • Grunze, H.1    Vieta, E.2    Goodwin, G.3
  • 24
    • 77649207564 scopus 로고    scopus 로고
    • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression
    • Grunze H, Vieta E, Goodwin G et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J. Biol. Psychiatry 11, 81-109 (2010).
    • (2010) World J. Biol. Psychiatry , vol.11 , pp. 81-109
    • Grunze, H.1    Vieta, E.2    Goodwin, G.3
  • 25
    • 78651023893 scopus 로고
    • Lithium salts in the treatment of psychotic excitement
    • Cade JF. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 2(10), 349-352 (1949).
    • (1949) Med. J. Aust. , vol.2 , Issue.10 , pp. 349-352
    • Cade, J.F.1
  • 26
  • 27
    • 0033924272 scopus 로고    scopus 로고
    • In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium
    • Kilts CD. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. J. Clin. Psychiatry 61(Suppl. 9), 41-46 (2000).
    • (2000) J. Clin. Psychiatry , vol.61 , Issue.SUPPL. 9 , pp. 41-46
    • Kilts, C.D.1
  • 28
    • 0029028026 scopus 로고
    • Clinical relevance of drug interactions with lithium
    • Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin. Pharmacokinet. 29(3), 172-191 (1995).
    • (1995) Clin. Pharmacokinet. , vol.29 , Issue.3 , pp. 172-191
    • Finley, P.R.1    Warner, M.D.2    Peabody, C.A.3
  • 31
    • 0024341795 scopus 로고
    • Neural and developmental actions of lithium: A unifying hypothesis
    • Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59(3), 411-419 (1989).
    • (1989) Cell , vol.59 , Issue.3 , pp. 411-419
    • Berridge, M.J.1    Downes, C.P.2    Hanley, M.R.3
  • 32
    • 0029776032 scopus 로고    scopus 로고
    • A molecular mechanism for the effect of lithium on development
    • Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93(16), 8455-8459 (1996).
    • (1996) Proc. Natl Acad. Sci. USA , vol.93 , Issue.16 , pp. 8455-8459
    • Klein, P.S.1    Melton, D.A.2
  • 33
    • 0034141704 scopus 로고    scopus 로고
    • Lithium therapy and signal transduction
    • Williams RS, Harwood AJ. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 21(2), 61-64 (2000).
    • (2000) Trends Pharmacol. Sci. , vol.21 , Issue.2 , pp. 61-64
    • Williams, R.S.1    Harwood, A.J.2
  • 34
    • 38949167104 scopus 로고    scopus 로고
    • A systematic review of existing data on long-term lithium therapy: Neuroprotective or neurotoxic?
    • Fountoulakis KN, Vieta E, Bouras C et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int. J. Neuropsychopharmacol. 11(2), 269-287 (2008).
    • (2008) Int. J. Neuropsychopharmacol. , vol.11 , Issue.2 , pp. 269-287
    • Fountoulakis, K.N.1    Vieta, E.2    Bouras, C.3
  • 35
    • 0026567408 scopus 로고
    • Chronic lithium administration alters a prominent PKC substrate in rat hippocampus
    • Lenox RH, Watson DG, Patel J, Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 570(1-2), 333-340 (1992).
    • (1992) Brain Res. , vol.570 , Issue.1-2 , pp. 333-340
    • Lenox, R.H.1    Watson, D.G.2    Patel, J.3    Ellis, J.4
  • 37
    • 13344287029 scopus 로고    scopus 로고
    • Ion homeostasis and the mechanism of action of lithium
    • El-Mallakh RS. Ion homeostasis and the mechanism of action of lithium. Clin. Neurosci. Res. 4(3-4), 227-231 (2004).
    • (2004) Clin. Neurosci. Res. , vol.4 , Issue.3-4 , pp. 227-231
    • El-Mallakh, R.S.1
  • 38
    • 66049113360 scopus 로고    scopus 로고
    • Glutamate-mediated calcium signaling: A potential target for lithium action
    • Sourial-Bassillious N, Rydelius PA, Aperia A, Aizman O. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 161(4), 1126-1134 (2009).
    • (2009) Neuroscience , vol.161 , Issue.4 , pp. 1126-1134
    • Sourial-Bassillious, N.1    Rydelius, P.A.2    Aperia, A.3    Aizman, O.4
  • 39
    • 0032493304 scopus 로고    scopus 로고
    • Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex
    • Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc. Natl Acad. Sci. USA 95(14), 8363-8368 (1998).
    • (1998) Proc. Natl Acad. Sci. USA , vol.95 , Issue.14 , pp. 8363-8368
    • Dixon, J.F.1    Hokin, L.E.2
  • 40
    • 77449095540 scopus 로고    scopus 로고
    • Mood-stabilizers target the brain arachidonic acid cascade
    • Rao JS, Rapoport SI. Mood-stabilizers target the brain arachidonic acid cascade. Curr. Mol. Pharmacol. 2(2), 207-214 (2009).
    • (2009) Curr. Mol. Pharmacol. , vol.2 , Issue.2 , pp. 207-214
    • Rao, J.S.1    Rapoport, S.I.2
  • 41
    • 79953043445 scopus 로고    scopus 로고
    • Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients
    • DOI: 10.1038/mp.2009.137 Epub ahead of print
    • Kim HW, Rapoport SI, Rao JS. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol. Psychiatry DOI: 10.1038/ mp.2009.137 (2009) (Epub ahead of print).
    • (2009) Mol. Psychiatry
    • Kim, H.W.1    Rapoport, S.I.2    Rao, J.S.3
  • 42
    • 0021745326 scopus 로고
    • Lithium intoxication associated with acute renal failure
    • Fenves AZ, Emmett M, White MG. Lithium intoxication associated with acute renal failure. South Med. J. 77(11), 1472-1474 (1984).
    • (1984) South Med. J. , vol.77 , Issue.11 , pp. 1472-1474
    • Fenves, A.Z.1    Emmett, M.2    White, M.G.3
  • 43
    • 0027942729 scopus 로고
    • Lithium-and carbamazepine-associated sinus node dysfunction: Nine-year experience in a psychiatric hospital
    • Steckler TL. Lithium-and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hospital. J. Clin. Psychopharmacol. 14(5), 336-339 (1994).
    • (1994) J. Clin. Psychopharmacol. , vol.14 , Issue.5 , pp. 336-339
    • Steckler, T.L.1
  • 44
    • 0020070498 scopus 로고
    • Cardiac effects of lithium therapy in man: A review
    • Mitchell JE, Mackenzie TB. Cardiac effects of lithium therapy in man: a review. J. Clin. Psychiatry 43(2), 47-51 (1982).
    • (1982) J. Clin. Psychiatry , vol.43 , Issue.2 , pp. 47-51
    • Mitchell, J.E.1    MacKenzie, T.B.2
  • 45
    • 0029864621 scopus 로고    scopus 로고
    • Lithium induced polyuria and renal vasopressin receptor density
    • Hensen J, Haenelt M, Gross P. Lithium induced polyuria and renal vasopressin receptor density. Nephrol. Dial. Transplant. 11(4), 622-627 (1996).
    • (1996) Nephrol. Dial. Transplant. , vol.11 , Issue.4 , pp. 622-627
    • Hensen, J.1    Haenelt, M.2    Gross, P.3
  • 46
    • 0033012920 scopus 로고    scopus 로고
    • Lithium and the kidney: An updated review
    • Gitlin M. Lithium and the kidney: an updated review. Drug Saf. 20, 231-243 (1999).
    • (1999) Drug Saf. , vol.20 , pp. 231-243
    • Gitlin, M.1
  • 47
    • 77449135723 scopus 로고    scopus 로고
    • Chronic renal complications induced by lithium
    • Le Roy V, Delmas Y, Verdoux H. Chronic renal complications induced by lithium. Encephale 35(6), 605-610 (2009).
    • (2009) Encephale , vol.35 , Issue.6 , pp. 605-610
    • Le Roy, V.1    Delmas, Y.2    Verdoux, H.3
  • 49
    • 0033042398 scopus 로고    scopus 로고
    • Effect of lithium mainteinance therapy on thyroid and parathyroid function
    • Kusalic M, Engelsmann F. Effect of lithium mainteinance therapy on thyroid and parathyroid function. J. Psychiatry Neurosci. 24, 227-233 (1999).
    • (1999) J. Psychiatry Neurosci. , vol.24 , pp. 227-233
    • Kusalic, M.1    Engelsmann, F.2
  • 51
    • 0016162895 scopus 로고
    • Ebsteins anomaly and other congenital heart defects
    • Nora JJ, Nora AH, Toews WH. Ebsteins anomaly and other congenital heart defects. Lancet 2, 594-595 (1974).
    • (1974) Lancet , vol.2 , pp. 594-595
    • Nora, J.J.1    Nora, A.H.2    Toews, W.H.3
  • 52
    • 36348946863 scopus 로고    scopus 로고
    • Psychotropic medication during pregnancy and lactation
    • Menon SJ. Psychotropic medication during pregnancy and lactation. Arch. Gynecol. Obstet. 277, 1-13 (2008).
    • (2008) Arch. Gynecol. Obstet. , vol.277 , pp. 1-13
    • Menon, S.J.1
  • 53
    • 0020516123 scopus 로고
    • Lithium and pregnancy: A cohort study on manic depressive women
    • Kallen B, Tandberg A. Lithium and pregnancy: a cohort study on manic depressive women. Acta Psychiatrica 68, 134-139 (1983).
    • (1983) Acta Psychiatrica , vol.68 , pp. 134-139
    • Kallen, B.1    Tandberg, A.2
  • 54
    • 0017096522 scopus 로고
    • What happenen later to the lithium babies? A follow-up study of children born without malformations
    • Schou M. What happenen later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr. Scand. 54, 193-197 (1976).
    • (1976) Acta Psychiatr. Scand. , vol.54 , pp. 193-197
    • Schou, M.1
  • 55
    • 0035989574 scopus 로고    scopus 로고
    • Managing bipolar disorder during pregnancy: Weighing the risks and benefits
    • Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can. J. Psychiatry 47, 426-436 (2002).
    • (2002) Can. J. Psychiatry , vol.47 , pp. 426-436
    • Viguera, A.C.1    Cohen, L.S.2    Baldessarini, R.J.3    Nonacs, R.4
  • 56
    • 66249149030 scopus 로고    scopus 로고
    • Lithium: Updated human knowledge using an evidence-based approach: Part III: Clinical safety
    • Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23(5), 397-418 (2009).
    • (2009) CNS Drugs , vol.23 , Issue.5 , pp. 397-418
    • Grandjean, E.M.1    Aubry, J.M.2
  • 57
    • 0029903292 scopus 로고    scopus 로고
    • Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium
    • Granneman GR, Schneck DW, Cavanaugh JH, Witt GF. Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. J. Clin. Psychiatry 57(5), 204-206 (1996).
    • (1996) J. Clin. Psychiatry , vol.57 , Issue.5 , pp. 204-206
    • Granneman, G.R.1    Schneck, D.W.2    Cavanaugh, J.H.3    Witt, G.F.4
  • 58
    • 0021682578 scopus 로고
    • Lithium-carbamazepine neurotoxicity and risk factors
    • Shukla S, Godwin CD, Long LE, Miller MG. Lithium-carbamazepine neurotoxicity and risk factors. Am. J. Psychiatry 141(12), 1604-1606 (1984).
    • (1984) Am. J. Psychiatry , vol.141 , Issue.12 , pp. 1604-1606
    • Shukla, S.1    Godwin, C.D.2    Long, L.E.3    Miller, M.G.4
  • 59
    • 0028894053 scopus 로고
    • Serotonergic syndrome in combination therapy with lithium and fluoxetine
    • Karle J, Bjrndal F. Serotonergic syndrome in combination therapy with lithium and fluoxetine. Ugeskr. Laeger. 157(9), 1204-1205 (1995).
    • (1995) Ugeskr. Laeger. , vol.157 , Issue.9 , pp. 1204-1205
    • Karle, J.1    Bjrndal, F.2
  • 60
    • 0030919795 scopus 로고    scopus 로고
    • Serotonin syndrome after lithium add-on medication to paroxetine
    • Sobanski T, Bagli M, Laux G, Rao ML. Serotonin syndrome after lithium add-on medication to paroxetine. Pharmacopsychiatry 30(3), 106-107 (1997).
    • (1997) Pharmacopsychiatry , vol.30 , Issue.3 , pp. 106-107
    • Sobanski, T.1    Bagli, M.2    Laux, G.3    Rao, M.L.4
  • 61
    • 0031455648 scopus 로고    scopus 로고
    • A case of serotonin syndrome caused by venlafaxine and lithium
    • Mekler G, Woggon B. A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry 30(6), 272-273 (1997).
    • (1997) Pharmacopsychiatry , vol.30 , Issue.6 , pp. 272-273
    • Mekler, G.1    Woggon, B.2
  • 62
    • 0027144398 scopus 로고
    • Serotonin syndrome induced by fluvoxamine-lithium interaction [3]
    • Ohman R, Spigset O. Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 26(6), 263-264 (1993). (Pubitemid 24010260)
    • (1993) Pharmacopsychiatry , vol.26 , Issue.6 , pp. 263-264
    • Ohman, R.1    Spigset, O.2
  • 63
    • 0030062506 scopus 로고    scopus 로고
    • Lithium and angiotensin-converting enzyme inhibitors: Evaluation of a potential interaction
    • Finley PR, OBrien JG, Coleman RW. Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J. Clin. Psychopharmacol. 16(1), 68-71 (1996).
    • (1996) J. Clin. Psychopharmacol. , vol.16 , Issue.1 , pp. 68-71
    • Finley, P.R.1    Obrien, J.G.2    Coleman, R.W.3
  • 64
    • 70849100305 scopus 로고    scopus 로고
    • Lithium and antihypertensive medication: A potentially dangerous interaction
    • Handler J. Lithium and antihypertensive medication: a potentially dangerous interaction. J. Clin. Hypertens. 11(12) (2009).
    • (2009) J. Clin. Hypertens. , vol.11 , Issue.12
    • Handler, J.1
  • 65
    • 77950819930 scopus 로고    scopus 로고
    • Anticonvulsants in bipolar disorder
    • Grunze HC. Anticonvulsants in bipolar disorder. Ment. Health 19(2), 127-141 (2010).
    • (2010) Ment. Health , vol.19 , Issue.2 , pp. 127-141
    • Grunze, H.C.1
  • 66
    • 0016424327 scopus 로고
    • Dipropylacetamide in the treatment of manic-depressive psychosis
    • Lambert PA, Carraz G, Borselli S et al. Dipropylacetamide in the treatment of manic-depressive psychosis. Encephale 1(1), 25-31 (1975).
    • (1975) Encephale , vol.1 , Issue.1 , pp. 25-31
    • Lambert, P.A.1    Carraz, G.2    Borselli, S.3
  • 67
    • 4243196940 scopus 로고    scopus 로고
    • Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers
    • Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol. Psychiatry 9(8), 734-755 (2004).
    • (2004) Mol. Psychiatry , vol.9 , Issue.8 , pp. 734-755
    • Gould, T.D.1    Quiroz, J.A.2    Singh, J.3    Zarate, C.A.4    Manji, H.K.5
  • 69
    • 0033926889 scopus 로고    scopus 로고
    • Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis
    • Ueda Y, Willmore LJ. Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis. Exp. Brain Res. 133(3), 334-339 (2000).
    • (2000) Exp. Brain Res. , vol.133 , Issue.3 , pp. 334-339
    • Ueda, Y.1    Willmore, L.J.2
  • 70
    • 4344600690 scopus 로고    scopus 로고
    • Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: Valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels
    • Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels. J. Clin. Psychiatry 65(6), 738-739 (2004).
    • (2004) J. Clin. Psychiatry , vol.65 , Issue.6 , pp. 738-739
    • Stahl, S.M.1
  • 71
    • 70350161413 scopus 로고    scopus 로고
    • PtdIns(3,4,5) P(3) and inositol depletion as a cellular target of mood stabilizers
    • Teo R, King J, Dalton E, Ryves J, Williams RS, Harwood AJ. PtdIns(3,4,5) P(3) and inositol depletion as a cellular target of mood stabilizers. Biochem. Soc. Trans. 37(Pt 5), 1110-1114 (2009).
    • (2009) Biochem. Soc. Trans. , vol.37 , Issue.PART 5 , pp. 1110-1114
    • Teo, R.1    King, J.2    Dalton, E.3    Ryves, J.4    Williams, R.S.5    Harwood, A.J.6
  • 73
    • 37849050187 scopus 로고    scopus 로고
    • Lipase and total amylase and its isoenzymes as markers of pancreatic injury in patients treated with antiepileptic drugs
    • Hermida Ameijeiras J, Tutor Crespo MJ, Tutor Valcarce CJ. Lipase and total amylase and its isoenzymes as markers of pancreatic injury in patients treated with antiepileptic drugs. Farm. Hosp. 31, 303-306 (2007).
    • (2007) Farm. Hosp. , vol.31 , pp. 303-306
    • Hermida Ameijeiras, J.1    Tutor Crespo, M.J.2    Tutor Valcarce, C.J.3
  • 74
    • 0031957837 scopus 로고    scopus 로고
    • A history of investigation on the mood stabilizing effect of carbamazepine in Japan
    • Okuma T, Kishimoto A. A history of investigation on the mood stabilizing effect of carbamazepine in Japan. Psychiatry Clin. Neurosci. 52(1), 3-12 (1998).
    • (1998) Psychiatry Clin. Neurosci. , vol.52 , Issue.1 , pp. 3-12
    • Okuma, T.1    Kishimoto, A.2
  • 75
    • 0018880191 scopus 로고
    • Carbamazepine in manic-depressive illness: A new treatment
    • Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am. J. Psychiatry 137(7), 782-790 (1980).
    • (1980) Am. J. Psychiatry , vol.137 , Issue.7 , pp. 782-790
    • Ballenger, J.C.1    Post, R.M.2
  • 76
    • 0033854906 scopus 로고    scopus 로고
    • Antiepileptic drug pharmacokinetics and interactions: Impact on treatment of epilepsy
    • Cloyd JC, Remmel RP. Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy. Pharmacotherapy 20(8 Pt 2), S139-S151 (2000).
    • (2000) Pharmacotherapy , vol.20 , Issue.8 PART 2
    • Cloyd, J.C.1    Remmel, R.P.2
  • 77
    • 0036239878 scopus 로고    scopus 로고
    • Carbamazepine augmentation in depressive patients non-responding to citalopram: A pharmacokinetic and clinical pilot study
    • Steinacher L, Vandel P, Zullino DF, Eap CB, Brawand-Amey M, Baumann P. Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study. Eur. Neuropsychopharmacol. 12(3), 255-260 (2002).
    • (2002) Eur. Neuropsychopharmacol. , vol.12 , Issue.3 , pp. 255-260
    • Steinacher, L.1    Vandel, P.2    Zullino, D.F.3    Eap, C.B.4    Brawand-Amey, M.5    Baumann, P.6
  • 78
    • 32244439673 scopus 로고    scopus 로고
    • Interactions between antiepileptic and antipsychotic drugs
    • Besag FM, Berry D. Interactions between antiepileptic and antipsychotic drugs. Drug Saf. 29(2), 95-118 (2006).
    • (2006) Drug Saf. , vol.29 , Issue.2 , pp. 95-118
    • Besag, F.M.1    Berry, D.2
  • 80
    • 70350161408 scopus 로고    scopus 로고
    • Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    • Bazinet RP. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? Biochem. Soc. Trans. 37(Pt 5), 1104-1109 (2009).
    • (2009) Biochem. Soc. Trans. , vol.37 , Issue.PART 5 , pp. 1104-1109
    • Bazinet, R.P.1
  • 81
    • 66649127822 scopus 로고    scopus 로고
    • Anticonvulsants in bipolar disorders: Current research and practice and future directions
    • Bowden CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord. 11(Suppl. 2), 20-33 (2009).
    • (2009) Bipolar Disord. , vol.11 , Issue.SUPPL. 2 , pp. 20-33
    • Bowden, C.L.1
  • 82
    • 32344440085 scopus 로고    scopus 로고
    • Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register
    • Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 77(2), 193-198 (2006).
    • (2006) J. Neurol. Neurosurg. Psychiatry , vol.77 , Issue.2 , pp. 193-198
    • Morrow, J.1    Russell, A.2    Guthrie, E.3
  • 83
    • 51449096208 scopus 로고    scopus 로고
    • Efficiency and safety of oxcarbazepine in mood disorders: A naturalistic study exploring the interest of plasma dosages
    • Misdrahi D, Tournier M, Droulout T et al. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. Eur. Psychiatry 23(6), 409-412 (2008).
    • (2008) Eur. Psychiatry , vol.23 , Issue.6 , pp. 409-412
    • Misdrahi, D.1    Tournier, M.2    Droulout, T.3
  • 84
    • 0242300756 scopus 로고    scopus 로고
    • Oxcarbazepine: Clinical experience with hospitalized psychiatric patients
    • Centorrino F, Albert MJ, Berry JM et al. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disord. 5(5), 370-374 (2003).
    • (2003) Bipolar Disord. , vol.5 , Issue.5 , pp. 370-374
    • Centorrino, F.1    Albert, M.J.2    Berry, J.M.3
  • 86
    • 20544438003 scopus 로고    scopus 로고
    • Antiepileptic drugs in mood-disordered patients
    • Gajwani P, Forsthoff A, Muzina D et al. Antiepileptic drugs in mood-disordered patients. Epilepsia 46(Suppl. 4), 38-44 (2005).
    • (2005) Epilepsia , vol.46 , Issue.SUPPL. 4 , pp. 38-44
    • Gajwani, P.1    Forsthoff, A.2    Muzina, D.3
  • 87
    • 0031756758 scopus 로고    scopus 로고
    • Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
    • Xie X, Hagan RM. Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38 (3), 119-130 (1998).
    • (1998) Neuropsychobiology , vol.38 , Issue.3 , pp. 119-130
    • Xie, X.1    Hagan, R.M.2
  • 88
    • 0023475125 scopus 로고
    • Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans
    • Cohen AF, Land GS, Breimer DD et al. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin. Pharmacol. Ther. 42, 535-541 (1987).
    • (1987) Clin. Pharmacol. Ther. , vol.42 , pp. 535-541
    • Cohen, A.F.1    Land, G.S.2    Breimer, D.D.3
  • 89
    • 0026005583 scopus 로고
    • Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy
    • Ramsay RE, Pellock JM, Garnett WR et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res. 10, 191-200 (1991).
    • (1991) Epilepsy Res. , vol.10 , pp. 191-200
    • Ramsay, R.E.1    Pellock, J.M.2    Garnett, W.R.3
  • 90
    • 0141961508 scopus 로고    scopus 로고
    • Lamotrigine: A review of its use in bipolar disorder
    • Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs 63(19), 2029-2050 (2003).
    • (2003) Drugs , vol.63 , Issue.19 , pp. 2029-2050
    • Goldsmith, D.R.1    Wagstaff, A.J.2    Ibbotson, T.3    Perry, C.M.4
  • 91
    • 0033937779 scopus 로고    scopus 로고
    • Adverse reactions to new anticonvulsant drugs
    • Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf. 23(1), 35-56 (2000).
    • (2000) Drug Saf. , vol.23 , Issue.1 , pp. 35-56
    • Wong, I.C.1    Lhatoo, S.D.2
  • 92
    • 77049289012 scopus 로고
    • Study of 300 case histories of psychotic patients treated with chlorpromazine in closed wards since 1952
    • Delay J, Deniker P, Ropert R. Study of 300 case histories of psychotic patients treated with chlorpromazine in closed wards since 1952, Encephale 45(4), 528-535 (1956).
    • (1956) Encephale , vol.45 , Issue.4 , pp. 528-535
    • Delay, J.1    Deniker, P.2    Ropert, R.3
  • 95
    • 2542572677 scopus 로고    scopus 로고
    • Pharmacotherapy for bipolar depression: An economic assessment
    • Bowden CL, Krishnan AA. Pharmacotherapy for bipolar depression: an economic assessment. Expert Opin. Pharmacoter. 5(5), 1101-1107 (2004).
    • (2004) Expert Opin. Pharmacoter. , vol.5 , Issue.5 , pp. 1101-1107
    • Bowden, C.L.1    Krishnan, A.A.2
  • 97
    • 77951798728 scopus 로고    scopus 로고
    • Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder
    • McIntyre RS. Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder. Expert Rev. Neurother. 10(5), 645-649 (2010).
    • (2010) Expert Rev. Neurother. , vol.10 , Issue.5 , pp. 645-649
    • McIntyre, R.S.1
  • 98
    • 0028790556 scopus 로고
    • First clinical experience with olanzapine (LY 170053): Results of an open-label and dose-ranging study in patients with schizophrenia
    • Baldwin DS, Montgomery SA. First clinical experience with olanzapine (LY 170053): results of an open-label and dose-ranging study in patients with schizophrenia. Int. Clin. Psychopharmacol. 10(4), 239-244 (1995).
    • (1995) Int. Clin. Psychopharmacol. , vol.10 , Issue.4 , pp. 239-244
    • Baldwin, D.S.1    Montgomery, S.A.2
  • 101
    • 0031595586 scopus 로고    scopus 로고
    • 5HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
    • Kapur S, Zipursky RB, Remington G et al. 5HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am. J. Psychiatry 155(7), 921-928 (1998).
    • (1998) Am. J. Psychiatry , vol.155 , Issue.7 , pp. 921-928
    • Kapur, S.1    Zipursky, R.B.2    Remington, G.3
  • 102
    • 0031030609 scopus 로고    scopus 로고
    • Disposition and biotransformation of the antipsychotic agent olanzapine in humans
    • Kassahun K, Mattiuz E, Nyhart E et al. Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab. Dispos. 25(1), 81-93(1997).
    • (1997) Drug Metab. Dispos. , vol.25 , Issue.1 , pp. 81-93
    • Kassahun, K.1    Mattiuz, E.2    Nyhart, E.3
  • 104
    • 0029983702 scopus 로고    scopus 로고
    • In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A
    • Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA. In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A. Br. J. Clin. Pharamacol. 41(3), 181-186 (1996).
    • (1996) Br. J. Clin. Pharamacol. , vol.41 , Issue.3 , pp. 181-186
    • Ring, B.J.1    Binkley, S.N.2    Vandenbranden, M.3    Wrighton, S.A.4
  • 106
    • 78650318125 scopus 로고    scopus 로고
    • American Diabetes Association Guidelines
    • American Diabetes Association Guidelines. Diabetes Care 32(Suppl.1) (2009).
    • (2009) Diabetes Care , vol.32 , Issue.SUPPL. 1
  • 108
    • 0032937396 scopus 로고    scopus 로고
    • Quetiapine fumarate (Seroquel®): A new atypical antipsychotic
    • Goldstein J. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barc.) 35, 193-210 (1999). (Pubitemid 29238943)
    • (1999) Drugs of Today , vol.35 , Issue.3 , pp. 193-210
    • Goldstein, J.M.1
  • 109
    • 77956100539 scopus 로고    scopus 로고
    • Real-world data on atypical antipsychotic medication side effects
    • Cascade E, Kalali AH, Mehra S, Meyer JM. Real-world data on atypical antipsychotic medication side effects, Psychiatry (Edgmont.) 7(7), 9-12 (2010).
    • (2010) Psychiatry (Edgmont.) , vol.7 , Issue.7 , pp. 9-12
    • Cascade, E.1    Kalali, A.H.2    Mehra, S.3    Meyer, J.M.4
  • 110
    • 78650327585 scopus 로고    scopus 로고
    • Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania
    • Copenhagen, Denmark, 14-16 April
    • Cutler A, Datto C, Nordenhem A et al. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Presented at: The 8th Annual International Review of Bipolar Disorders Conference. Copenhagen, Denmark, 14-16 April, 2008.
    • (2008) Presented At: The 8th Annual International Review of Bipolar Disorders Conference
    • Cutler, A.1    Datto, C.2    Nordenhem, A.3
  • 112
    • 77950809193 scopus 로고    scopus 로고
    • Role of extended release quetiapine in the management of bipolar disorders
    • Jurdi RK Al, Dixit LA, Sajatovic M. Role of extended release quetiapine in the management of bipolar disorders. Neuropsychiatr. Dis. Treat. 6, 29-35 (2010).
    • (2010) Neuropsychiatr. Dis. Treat. , vol.6 , pp. 29-35
    • Al Jurdi, R.K.1    Dixit, L.A.2    Sajatovic, M.3
  • 113
    • 77649134473 scopus 로고    scopus 로고
    • A double blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)
    • Young AH, Mc Elroy, Bauer M et al. A double blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J. Clin. Psychiatry 71, 150 (2010).
    • (2010) J. Clin. Psychiatry , vol.71 , pp. 150
    • Young, A.H.1    Elroy, M.2    Bauer, M.3
  • 114
    • 77649138108 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)
    • McElroy SL, Weisler RH, Chang W et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J. Clin. Psychiatry 71, 163 (2010).
    • (2010) J. Clin. Psychiatry , vol.71 , pp. 163
    • McElroy, S.L.1    Weisler, R.H.2    Chang, W.3
  • 115
    • 0028237637 scopus 로고
    • Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity
    • Leysen JE, Janssen PM, Megens AA, Schotte A. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J. Clin. Psychiatry 55, 5-12 (1994).
    • (1994) J. Clin. Psychiatry , vol.55 , pp. 5-12
    • Leysen, J.E.1    Janssen, P.M.2    Megens, A.A.3    Schotte, A.4
  • 116
    • 0029930927 scopus 로고    scopus 로고
    • Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptors binding
    • Schotte A, Janssen PF, Gommeren W et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptors binding. Psychopharmacology (Berl.) 124(1-2), 57-73 (1996).
    • (1996) Psychopharmacology (Berl.) , vol.124 , Issue.1-2 , pp. 57-73
    • Schotte, A.1    Janssen, P.F.2    Gommeren, W.3
  • 117
    • 0028361351 scopus 로고
    • The pharmacokinetics of risperidone in humans: A summary
    • Heykants J, Huang ML, Mannens G. The pharmacokinetics of risperidone in humans: a summary. J. Clin. Psychiatry 55, 13-17 (1994).
    • (1994) J. Clin. Psychiatry , vol.55 , pp. 13-17
    • Heykants, J.1    Huang, M.L.2    Mannens, G.3
  • 118
    • 27744476275 scopus 로고    scopus 로고
    • Intrinsic efficacy of antipsychotics at human D2, D3 and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
    • Burstein ES, Ma J, Wong S et al. Intrinsic efficacy of antipsychotics at human D2, D3 and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. J. Pharmacol. Exp. Ther. 315(3), 1278-1287 (2005).
    • (2005) J. Pharmacol. Exp. Ther. , vol.315 , Issue.3 , pp. 1278-1287
    • Burstein, E.S.1    Ma, J.2    Wong, S.3
  • 119
    • 0036089687 scopus 로고    scopus 로고
    • Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
    • Burris KD, Molski TF, Xu C et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. 302(1), 381-389 (2002).
    • (2002) J. Pharmacol. Exp. Ther. , vol.302 , Issue.1 , pp. 381-389
    • Burris, K.D.1    Molski, T.F.2    Xu, C.3
  • 120
    • 0037177358 scopus 로고    scopus 로고
    • The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
    • Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur. J. Pharmacol. 441(3), 137-140 (2002).
    • (2002) Eur. J. Pharmacol. , vol.441 , Issue.3 , pp. 137-140
    • Jordan, S.1    Koprivica, V.2    Chen, R.3    Tottori, K.4    Kikuchi, T.5    Altar, C.A.6
  • 121
    • 0042887023 scopus 로고    scopus 로고
    • Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
    • Shapiro DA, Renock S, Arrington E. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28(8), 1400-1411(2003).
    • (2003) Neuropsychopharmacology , vol.28 , Issue.8 , pp. 1400-1411
    • Shapiro, D.A.1    Renock, S.2    Arrington, E.3
  • 122
    • 34249284473 scopus 로고    scopus 로고
    • Intramuscular aripiprazole in the control of agitation
    • Currier GW, Citrome LL, Zimbroff DL et al. Intramuscular aripiprazole in the control of agitation. J. Psychiatr. Pract. 13(3), 159-169 (2007).
    • (2007) J. Psychiatr. Pract. , vol.13 , Issue.3 , pp. 159-169
    • Currier, G.W.1    Citrome, L.L.2    Zimbroff, D.L.3
  • 123
    • 21744459699 scopus 로고    scopus 로고
    • Switching outpatients with bipolar or schizoaffective disorder and substance abuse from their current antipsychotic to aripiprazole
    • Brown ES, Jeffress J, Liggin JD, Garza M, Beard L. Switching outpatients with bipolar or schizoaffective disorder and substance abuse from their current antipsychotic to aripiprazole. J. Clin. Psychiatry 66(6), 756-760 (2005).
    • (2005) J. Clin. Psychiatry , vol.66 , Issue.6 , pp. 756-760
    • Brown, E.S.1    Jeffress, J.2    Liggin, J.D.3    Garza, M.4    Beard, L.5
  • 124
    • 0036738786 scopus 로고    scopus 로고
    • Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    • Kane JM, Carson WH, Saha AR et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J. Clin. Psychiatry 63(9), 763-771 (2002).
    • (2002) J. Clin. Psychiatry , vol.63 , Issue.9 , pp. 763-771
    • Kane, J.M.1    Carson, W.H.2    Saha, A.R.3
  • 125
    • 0038488945 scopus 로고    scopus 로고
    • Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
    • Potkin SG, Saha AR, Kujawa MJ et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry 60(7), 681-690 (2003).
    • (2003) Arch. Gen. Psychiatry , vol.60 , Issue.7 , pp. 681-690
    • Potkin, S.G.1    Saha, A.R.2    Kujawa, M.J.3
  • 126
    • 17844379465 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of quetiapine: An atypical antipsychotic
    • De Vane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin. Pharmacokinet. 40, 509-522 (2001).
    • (2001) Clin. Pharmacokinet. , vol.40 , pp. 509-522
    • De Vane, C.L.1    Nemeroff, C.B.2
  • 127
    • 0037311477 scopus 로고    scopus 로고
    • Synergistic action of 5-HT2A antagonists and selective reuptake inhibitors in neuropsychiatric disorders
    • Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28(2), 402-412 (2003).
    • (2003) Neuropsychopharmacology , vol.28 , Issue.2 , pp. 402-412
    • Marek, G.J.1    Carpenter, L.L.2    McDougle, C.J.3    Price, L.H.4
  • 128
    • 28944452691 scopus 로고    scopus 로고
    • From clinical research to clinical practice: A 4-year review of ziprasidone
    • Nemeroff CB, Lieberman JA, Weiden PJ et al. From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr. 10(11), 1-20 (2005).
    • (2005) CNS Spectr. , vol.10 , Issue.11 , pp. 1-20
    • Nemeroff, C.B.1    Lieberman, J.A.2    Weiden, P.J.3
  • 129
    • 58649100010 scopus 로고    scopus 로고
    • Asenapine: A novel psychopharmacologic agent with a unique human receptor signature
    • Shahid M, Walker GB, Zorn SH, Wong EH. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J. Psychopharmacol. 23(1), 65-73 (2009).
    • (2009) J. Psychopharmacol. , vol.23 , Issue.1 , pp. 65-73
    • Shahid, M.1    Walker, G.B.2    Zorn, S.H.3    Wong, E.H.4
  • 130
    • 66649123127 scopus 로고    scopus 로고
    • Antipsychotic agents in the treatment of bipolar mania
    • Tohen M, Vieta E. Antipsychotic agents in the treatment of bipolar mania. Bipolar Disord. 11(2), 45-54 (2009).
    • (2009) Bipolar Disord. , vol.11 , Issue.2 , pp. 45-54
    • Tohen, M.1    Vieta, E.2
  • 131
    • 0031750352 scopus 로고    scopus 로고
    • Clozapine in bipolar disorder: Treatment implications for other atypical antipsychotics
    • Frye MA, Ketter TA, Altshuler Ll et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J. Affect. Disord. 48, 91-104 (1998).
    • (1998) J. Affect. Disord. , vol.48 , pp. 91-104
    • Frye, M.A.1    Ketter, T.A.2    Ll, A.3
  • 133
    • 12944286545 scopus 로고    scopus 로고
    • Clozapine in the treatment of refractory psychotic mania
    • Green AI, Tohen M, Patel JK. Clozapine in the treatment of refractory psychotic mania. Am. J. Psichiatry 157, 982-986 (2000).
    • (2000) Am. J. Psichiatry , vol.157 , pp. 982-986
    • Green, A.I.1    Tohen, M.2    Patel, J.K.3
  • 134
    • 16344363600 scopus 로고    scopus 로고
    • Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: A case series
    • Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. J. ECT 21, 31-34 (2005).
    • (2005) J. ECT , vol.21 , pp. 31-34
    • MacEdo-Soares, M.B.1    Moreno, R.A.2    Rigonatti, S.P.3    Lafer, B.4
  • 136
    • 56249131097 scopus 로고    scopus 로고
    • Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression
    • Hallam KT, Smith DI, Berk M. Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. J. Affect. Disord. 112, 212-218 (2009).
    • (2009) J. Affect. Disord. , vol.112 , pp. 212-218
    • Hallam, K.T.1    Smith, D.I.2    Berk, M.3
  • 137
    • 0034890446 scopus 로고    scopus 로고
    • Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression
    • Ciapparelli A, DellOsso L, Tundo A et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J. Clin. Psychiatry 62(7), 552-555 (2001).
    • (2001) J. Clin. Psychiatry , vol.62 , Issue.7 , pp. 552-555
    • Ciapparelli, A.1    Dellosso, L.2    Tundo, A.3
  • 139
    • 0033863937 scopus 로고    scopus 로고
    • Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group
    • Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch. Gen. Psychiatry 57(9), 841-849 (2000).
    • (2000) Arch. Gen. Psychiatry , vol.57 , Issue.9 , pp. 841-849
    • Tohen, M.1    Jacobs, T.G.2    Grundy, S.L.3
  • 142
    • 0036307574 scopus 로고    scopus 로고
    • Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety
    • Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 159(7), 1146-1154 (2002).
    • (2002) Am. J. Psychiatry , vol.159 , Issue.7 , pp. 1146-1154
    • Sachs, G.S.1    Grossman, F.2    Ghaemi, S.N.3    Okamoto, A.4    Bowden, C.L.5
  • 144
    • 0037707550 scopus 로고    scopus 로고
    • Long-term symptomatic status of bipolar i vs. bipolar II disorders
    • Judd LL, Schettler PJ, Akiskal HS et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int. J. Neuropsychopharmacol. 6(2), 127-137 (2003).
    • (2003) Int. J. Neuropsychopharmacol. , vol.6 , Issue.2 , pp. 127-137
    • Judd, L.L.1    Schettler, P.J.2    Akiskal, H.S.3
  • 145
    • 34547623406 scopus 로고    scopus 로고
    • Three times more days depressed than manic or hypomanic in both bipolar i and bipolar II disorder
    • Kupka RW, Altshuler LL, Nolen WA et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 9, 531-535 (2007).
    • (2007) Bipolar Disord. , vol.9 , pp. 531-535
    • Kupka, R.W.1    Altshuler, L.L.2    Nolen, W.A.3
  • 147
    • 0034666050 scopus 로고    scopus 로고
    • Models of bipolar disease and their clinical implications
    • Kupfer DJ. Models of bipolar disease and their clinical implications. Biol. Psychiatry 48(6), 428-429 (2000).
    • (2000) Biol. Psychiatry , vol.48 , Issue.6 , pp. 428-429
    • Kupfer, D.J.1
  • 148
    • 0036270011 scopus 로고    scopus 로고
    • The long-term natural history of the weekly symptomatic status of bipolar i disorder
    • Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry 59(6), 530-537 (2002).
    • (2002) Arch. Gen. Psychiatry , vol.59 , Issue.6 , pp. 530-537
    • Judd, L.L.1    Akiskal, H.S.2    Schettler, P.J.3
  • 149
    • 0032876736 scopus 로고    scopus 로고
    • Bipolar II disorder and suicidal behavior
    • Rihmer Z, Pestality P. Bipolar II disorder and suicidal behavior. Psychiatr. Clin. North Am. 22(3), 667-673 (1999).
    • (1999) Psychiatr. Clin. North Am. , vol.22 , Issue.3 , pp. 667-673
    • Rihmer, Z.1    Pestality, P.2
  • 150
    • 33845421095 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of mood disorders
    • Jarema M. Atypical antipsychotics in the treatment of mood disorders. Curr. Opin. Psychiatry 20(1), 23-29 (2007).
    • (2007) Curr. Opin. Psychiatry , vol.20 , Issue.1 , pp. 23-29
    • Jarema, M.1
  • 151
    • 47749129275 scopus 로고    scopus 로고
    • Quetiapine and classical mood stabilizer in the long-term treatment of bipolar disorder: A 4 years follow-up naturalistic study
    • Altamura AC, Mundo E, Dellosso B, Tacchini G, Buoli M, Calabrese JR. Quetiapine and classical mood stabilizer in the long-term treatment of bipolar disorder: a 4 years follow-up naturalistic study. J. Affect. Disord. 110(1-2), 135-141 (2008).
    • (2008) J. Affect. Disord. , vol.110 , Issue.1-2 , pp. 135-141
    • Altamura, A.C.1    Mundo, E.2    Dellosso, B.3    Tacchini, G.4    Buoli, M.5    Calabrese, J.R.6
  • 152
    • 75549086963 scopus 로고    scopus 로고
    • Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients
    • Tondo L, Baldessarini RJ. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol. Psichiatr. Soc. 18(3), 179-183 (2009).
    • (2009) Epidemiol. Psichiatr. Soc. , vol.18 , Issue.3 , pp. 179-183
    • Tondo, L.1    Baldessarini, R.J.2
  • 153
    • 77951968835 scopus 로고    scopus 로고
    • Lithium reduces pathological aggression and suicidality: A mini-review
    • Muller-Oelinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology 62(1), 43-49 (2010).
    • (2010) Neuropsychobiology , vol.62 , Issue.1 , pp. 43-49
    • Muller-Oelinghausen, B.1    Lewitzka, U.2
  • 154
    • 54349103020 scopus 로고    scopus 로고
    • Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: Fact or overinterpretation?
    • Grunze HC. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr. 13(9), 790-795 (2008).
    • (2008) CNS Spectr. , vol.13 , Issue.9 , pp. 790-795
    • Grunze, H.C.1
  • 155
    • 77954230593 scopus 로고    scopus 로고
    • Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: A randomized, double-blind, placebo-substitution study
    • Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am. J. Psychiatry 167(7), 792-800 (2010).
    • (2010) Am. J. Psychiatry , vol.167 , Issue.7 , pp. 792-800
    • Amsterdam, J.D.1    Shults, J.2
  • 156
    • 76449086363 scopus 로고    scopus 로고
    • Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy
    • Amsterdam JD, Wang G, Shults J. Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy. Acta Psychiatr. Scand. 121(3), 201-208 (2010).
    • (2010) Acta Psychiatr. Scand. , vol.121 , Issue.3 , pp. 201-208
    • Amsterdam, J.D.1    Wang, G.2    Shults, J.3
  • 157
    • 77952409605 scopus 로고    scopus 로고
    • Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode
    • Amsterdam JD, Shults J. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. J. Clin. Psychopharmacol. 30(3), 306-311 (2010).
    • (2010) J. Clin. Psychopharmacol. , vol.30 , Issue.3 , pp. 306-311
    • Amsterdam, J.D.1    Shults, J.2
  • 158
    • 0029806545 scopus 로고    scopus 로고
    • Novel antipsychotics and the problem of clinical stabilization in schizophrenia: Are they stabilizer rather than typical compounds?
    • Altamura AC. Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they stabilizer rather than typical compounds? Int. Clin. Psychopharmacol. 11(3), 153-155 (1996).
    • (1996) Int. Clin. Psychopharmacol. , vol.11 , Issue.3 , pp. 153-155
    • Altamura, A.C.1
  • 159
    • 77952992661 scopus 로고    scopus 로고
    • From the concept of antipsychotic to that of multidimensional normostabilizer: The clinical-therapeutic itinerary of schizophrenia
    • Altamura AC. From the concept of antipsychotic to that of multidimensional normostabilizer: the clinical-therapeutic itinerary of schizophrenia. Giorn. Ital. Psicopat. 16, 87-103 (2010).
    • (2010) Giorn. Ital. Psicopat. , vol.16 , pp. 87-103
    • Altamura, A.C.1
  • 160
    • 77957852355 scopus 로고    scopus 로고
    • Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder
    • Post RM, Altshuler LL, Frye MA et al. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J. Clin. Psychiatry 71(9), 1176-1186 (2010).
    • (2010) J. Clin. Psychiatry , vol.71 , Issue.9 , pp. 1176-1186
    • Post, R.M.1    Altshuler, L.L.2    Frye, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.